Dresden researchers have pioneered a brain-network bio-inspired algorithm to predict new therapeutic targets of approved drugs

An international team of scientists led by Dr. Carlo Vittorio Cannistraci, Junior Group Leader of the Biomedical Cybernetics lab at the BIOTEChnology Center TU Dresden, has developed a powerful computational method that can exploit the principles of brain-network self-organization to predict new, highly reliable drug-target interactions using only the topology of molecular networks without any further information about the chemical structures of the drugs.

Press release